TrialBMC psychiatry2016

A double-blind randomized study assessing safety and efficacy following one-year adjunctive treatment with bitopertin, a glycine reuptake inhibitor, in Japanese patients with schizophrenia.

Yoshio Hirayasu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.